Transactions

Our broad-based transaction experience extends across a range of situations, industries and enterprise values

Type

Industry

Mylan N.V.

Announced: July 29, 2019
Value: $50 billion
Status: Pending

Financial advisor to Mylan on its combination with Upjohn in an all-stock Reverse Morris Trust transaction

CBS Corporation

Announced: August 13, 2019
Value: $48 billion
Status: Pending

Financial advisor to the Special Committee of CBS’s Board of Directors on the CBS and Viacom all-stock merger forming ViacomCBS Inc.

FIS

Announced: March 18, 2019
Value: $43 billion
Status: Closed

Financial advisor to FIS on its acquisition of Worldpay

Thomson Reuters

Announced: August 1, 2019
Value: $27 billion
Status: Pending

Financial advisor to Thomson Reuters, together with private equity funds affiliated with Blackstone, on the sale of Refinitiv to the London Stock Exchange Group plc

Array Biopharma Inc.

Announced: June 17, 2019
Value: $11.8 billion
Status: Closed

Exclusive financial advisor to Array Biopharma on its sale to Pfizer

Riverstone Holdings LLC

Announced: November 5, 2019
Value: $6.1 billion
Status: Pending

Exclusive financial advisor to Pattern Energy Group Holdings 2 LP (P2) and Riverstone Holdings in connection with Canada Pension Plan Investment Board and Riverstone Holdings combination of Pattern Energy and P2 into an integrated renewable energy company

Auris Health, Inc.

Announced: February 13, 2019
Value: Up to $5.8 billion
Status: Closed

Exclusive financial advisor to Auris Health on its sale to Johnson & Johnson

Hasbro, Inc.

Announced: August 22, 2019
Value: £3.3 billion
Status: Pending

Exclusive financial advisor to Hasbro on its acquisition of Entertainment One Ltd.

Gilead Sceinces, Inc.

Announced: July 14, 2019
Value: $5.1 billion
Status: Pending

Financial advisor to Gilead on its 10-year global R&D collaboration with Galapagos NV

Waste Management, Inc.

Announced: April 15, 2019
Value: $4.9 billion
Status: Pending

Exclusive financial advisor to Waste Management on its acquisition of Advanced Disposal

Spark Therapeutics, Inc

Announced: February 25, 2019
Value: $4.8 billion
Status: Pending

Exclusive financial advisor to Spark on its sale to Roche Holding AG

Anixter International Inc.

Announced: October 30, 2019
Value: $3.8 billion
Status: Pending

Lead financial advisor to Anixter on its sale to Clayton, Dubilier & Rice

Exact Sciences Corporation

Announced: July 29, 2019
Value: $2.8 billion
Status: Closed

Financial advisor to Exact Sciences on its acquisition of Genomic Health

Cision Ltd.

Announced: October 15, 2019
Value: $2.7 billion
Status: Pending

Financial advisor to Cision on its sale to an affiliate of Platinum Equity

Ra Pharmaceuticals, Inc.

Announced: October 10, 2019
Value: $2.5 billion
Status: Pending

Exclusive financial advisor to Ra Pharma on its sale to UCB S.A.

Campbell Soup Company

Announced: August 2, 2019
Value: $2.2 billion
Status: Pending

Financial advisor to Campbell on the sale of Arnott's and certain Campbell's international operations to KKR

Peloton Therapeutics, Inc.

Announced: May 21, 2019
Value: Up to $2.2 billion
Status: Closed

Exclusive financial advisor to Peloton on its sale to Merck

Alder Biopharmaceuticals, Inc.

Announced: September 16, 2019
Value: $1.95 billion
Status: Pending

Exclusive financial advisor to Alder on its sale to Lundbeck

Neurocrine Biosciences, Inc.

Announced: January 29, 2019
Value: Up to $1.9 billion
Status: Closed

Exclusive financial advisor to Neurocrine on its strategic collaboration with Voyager Therapeutics

Coty Inc.

Announced: March 18, 2019
Value: $1.75 billion
Status: Pending

Exclusive independent financial advisor to the Special Committee of the Board of Directors of Coty in connection with JAB's tender offer

PepsiCo Inc.

Announced: July 19, 2019
Value: $1.7 billion
Status: Pending

Financial advisor to PepsiCo on its acquisition of Pioneer Food Group Ltd.

Harry’s Inc.

Announced: May 9, 2019
Value: $1.4 billion
Status: Pending

Exclusive financial advisor to Harry's on its combination with Edgewell Personal Care Company

Ipsen

Announced: February 25, 2019
Value: $1.3 billion
Status: Closed

Exclusive financial advisor to Ipsen on its acquisition of Clementia Pharmaceuticals

Achillion Pharmaceuticals, Inc.

Announced: October 16, 2019
Value: $1.2 billion
Status: Pending

Exclusive financial advisor to Achillion on its sale to Alexion

Catalent, Inc.

Announced: April 15, 2019
Value: $1.2 billion
Status: Closed

Exclusive financial advisor to Catalent on its acquisition of Paragon Bioservices from NewSpring Health Capital and Camden Partners, financed in part by $650 million of a new series of convertible preferred stock issued to Leonard Green & Partners

Ocado Group plc

Announced: February 27, 2019
Value: £750 million
Status: Pending

Financial advisor to Ocado on its joint venture with Marks and Spencer Group plc

I Squared Capital Advisors, LLC

Announced: June 25, 2019
Value: $1.1 billion
Status: Pending

Exclusive financial advisor to I Squared and Cube Hydro Partners on the sale of Cube Hydro to Ontario Power Generation

Smart & Final Stores, Inc.

Announced: April 16, 2019
Value: $1.1 billion
Status: Closed

Financial advisor to the Smart & Final Strategic Review Committee on its sale to Apollo Management

The Simply Good Foods Company

Announced: August 21, 2019
Value: $1 billion
Status: Pending

Financial advisor to Simply Good Foods on its acquisition of Quest Nutrition, LLC

Nightstar Therapeutics plc

Announced: March 4, 2019
Value: $877 million
Status: Closed

Exclusive financial advisor to Nightstar on its sale to Biogen

Axioma Inc.

Announced: April 9, 2019
Value: $850 million
Status: Pending

Exclusive financial advisor to Axioma on its combination with Deutsche Börse index businesses and a minority equity investment from General Atlantic

Perrigo Company plc

Announced: May 9, 2019
Value: $750 million
Status: Closed

Exclusive financial advisor to Perrigo on its acquisition of Ranir LLC

Western Union Company

Announced: February 28, 2019
Value: $750 million
Status: Closed

Exclusive financial advisor to Western Union on its sale of Speedpay to ACI Worldwide

Omega Healthcare Investors, Inc.

Announced: January 2, 2019
Value: $600 million
Status: Closed

Exclusive financial advisor to Omega on its acquisition of MedEquities Realty Trust

Campbell Soup Company

Announced: April 12, 2019
Value: $510 million
Status: Closed

Financial advisor to Campbell on its divestiture of Bolthouse Farms to Butterfly Equity

Daily Mail and General Trust plc

Announced: August 26, 2019
Value: $364 million
Status: Pending

Exclusive financial advisor to DMGT on the sale of Genscape to Verisk

Campbell Soup Company

Announced: July 12, 2019
Value: $300 million
Status: Pending

Financial advisor to Campbell on its sale of Kelsen Group to an affiliate of Ferrero SpA

AT&T Inc.

Announced: October 28, 2019

Advised AT&T on its discussions with shareholder activist Elliott Management

Cloud Peak Energy Inc.

Announced: October 24, 2019
Status: Completed

Exclusive investment banker in Cloud Peak's chapter 11 restructuring, including the sale of substantially all of Cloud Peak's assets to Navajo Transitional Energy Company, LLC

Hudson's Bay Company

Announced: October 21, 2019
Status: Pending

Special advisor to the Special Committee of the Hudson's Bay Company Board of Directors with regards to the proposal from a group of majority HBC shareholders to take the company private

Thomson Reuters

Announced: October 4, 2019
Status: Closed

Exclusive financial advisor to Thomson Reuters on its acquisition of FC Business Intelligence (FCBI) from Lloyds Development Capital

Daniele Inc

Announced: September 3, 2019
Status: Closed

Exclusive financial advisor to Daniele on its sale to Entrepreneurial Equity Partners, LLC

Shields Health Solutions

Announced: July 31, 2019
Status: Closed

Exclusive financial advisor to Shields Health on equity investments made by Welsh, Carson, Anderson & Stowe and Walgreens

Thomson Reuters

Announced: July 18, 2019
Status: Closed

Exclusive financial advisor to Thomson Reuters on its acquisition of HighQ

Moody's Corp.

Announced: July 16, 2019
Status: Pending

Exclusive financial advisor to Moody's on the sale of its Moody's Analytics Knowledge Services (MAKS) to Equistone Partners Europe Ltd.

Thomson Reuters

Announced: June 21, 2019
Status: Closed

Exclusive financial advisor to Thomson Reuters on its acquisition of Capital Confirmation Inc. (also known as Confirmation.com), a Great Hill Partners portfolio company

Beacon Health Options

Announced: June 6, 2019
Status: Pending

Exclusive financial advisor to Beacon on its sale to Anthem, Inc.

The Hain Celestial Group Inc.

Announced: May 9, 2019
Status: Closed

Financial advisor to Hain on the sale all of its equity interest in Hain Pure Protein to Aterian Investment Partners

Amer Sports Corporation

Announced: March 15, 2019
Status: Closed

Exclusive financial advisor to Amer Sports on the strategic review of its Cycling business and on its intended divestiture of Mavic S.A.S. to Regent

Qualcomm Incorporated

Announced: February 11, 2019
Status: Closed

Exclusive financial advisor to Qualcomm on its sale of Qualcomm Life, Inc. to Francisco Partners

Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

At Centerview Partners, our success depends on our people, and we are always looking for talented individuals. Please let us know if you would like to learn more about a career at Centerview.
Our Partners have worked on many of the largest and most complex transactions and corporate situations around the globe over the course of their careers. Learn more about who we are.